Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3,3-Dimethyl-1-butanol (DMB) is an orally active compound that inhibits trimethylamine (TMA) and trimethylamine N-oxide (TMAO), along with the signaling pathways of p65 NF-κB and TGF-β1/Smad3. It holds potential for use in preventing or treating cardiovascular disease (CVD).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | Inquiry | |
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | 3,3-Dimethyl-1-butanol (DMB) is an orally active compound that inhibits trimethylamine (TMA) and trimethylamine N-oxide (TMAO), along with the signaling pathways of p65 NF-κB and TGF-β1/Smad3. It holds potential for use in preventing or treating cardiovascular disease (CVD). |
Synonyms | Neohexanol, DMB, DMB ; Neohexanol |
Molecular Weight | 102.17 |
Formula | C6H14O |
CAS No. | 624-95-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3,3-Dimethyl-1-butanol 624-95-3 Neohexanol DMB DMB ; Neohexanol DMB ; Neohexanol inhibitor inhibit